tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Financial Statements

Compare
138 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently $2.26M. The company's EPS TTM is $-1.65; its P/E ratio is -0.11; Dermata Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-1.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -322.00
Operating Income$ -12.51M$ -8.04M$ -9.67M$ -7.86M$ -3.17M
EBITDA$ -12.29M$ 247.22K$ -9.61M$ -7.86M$ -3.04M
Net Income$ -12.29M$ -7.79M$ -9.61M$ -7.90M$ -3.24M
Balance Sheet
Cash & Short-Term Investments$ 3.16M$ 7.44M$ 6.24M$ 10.80M$ 530.40K
Total Assets$ 3.53M$ 7.98M$ 6.94M$ 11.62M$ 605.45K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 3.55M
Net Debt$ -3.16M$ -7.44M$ -6.24M$ -10.80M$ 3.02M
Total Liabilities$ 1.97M$ 1.62M$ 922.63K$ 1.52M$ 3.78M
Stockholders' Equity$ 1.56M$ 6.36M$ 6.02M$ 10.11M$ -3.18M
Cash Flow
Free Cash Flow$ -11.16M$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Operating Cash Flow$ -11.16M$ -6.41M$ -8.83M$ -5.69M$ -4.03M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 6.89M$ 7.61M$ 4.28M$ 15.96M$ 2.57M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS